Residual androgen depending in hormone-resistant prostate cancer.
Fosså
S D
SD
Department of Medical Oncology & Radiotherapy, The Norwegian Radium Hospital, Oslo.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D013739:Testosterone / Q000097:blood*
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D013739:Testosterone